vs
IDEAYA Biosciences, Inc.（IDYA）与IMAX（IMAX）财务数据对比。点击上方公司名可切换其他公司
IDEAYA Biosciences, Inc.的季度营收约是IMAX的1.7倍（$207.8M vs $125.2M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs 0.5%，领先56.9%），IDEAYA Biosciences, Inc.自由现金流更多（$142.2M vs $28.0M）
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
IMAX公司是加拿大的影视放映技术企业，1967年创立于蒙特利尔，总部位于多伦多地区，在纽约、洛杉矶均设有业务点。核心业务包括IMAX摄影机与放映系统的设计制造，同时面向全球合作影院提供影片开发、制作、后期及发行服务，是沉浸式观影技术领域的领先企业。
IDYA vs IMAX — 直观对比
营收规模更大
IDYA
是对方的1.7倍
$125.2M
净利率更高
IDYA
高出56.9%
0.5%
自由现金流更多
IDYA
多$114.2M
$28.0M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $207.8M | $125.2M |
| 净利润 | $119.2M | $637.0K |
| 毛利率 | — | 57.6% |
| 营业利润率 | 52.2% | 19.3% |
| 净利率 | 57.4% | 0.5% |
| 营收同比 | — | 35.1% |
| 净利润同比 | 330.1% | -88.0% |
| 每股收益（稀释后） | $1.33 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDYAIMAX
| Q4 25 | — | $125.2M | ||
| Q3 25 | $207.8M | $106.7M | ||
| Q2 25 | — | $91.7M | ||
| Q1 25 | — | $86.7M | ||
| Q4 24 | — | $92.7M | ||
| Q3 24 | $0 | $91.5M | ||
| Q2 24 | $0 | $89.0M | ||
| Q1 24 | $0 | $79.1M |
净利润IDYAIMAX
| Q4 25 | — | $637.0K | ||
| Q3 25 | $119.2M | $20.7M | ||
| Q2 25 | — | $11.3M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | $-51.8M | $13.9M | ||
| Q2 24 | $-52.8M | $3.6M | ||
| Q1 24 | $-39.6M | $3.3M |
毛利率IDYAIMAX
| Q4 25 | — | 57.6% | ||
| Q3 25 | — | 63.1% | ||
| Q2 25 | — | 58.5% | ||
| Q1 25 | — | 61.4% | ||
| Q4 24 | — | 52.2% | ||
| Q3 24 | — | 55.8% | ||
| Q2 24 | — | 49.4% | ||
| Q1 24 | — | 59.3% |
营业利润率IDYAIMAX
| Q4 25 | — | 19.3% | ||
| Q3 25 | 52.2% | 27.2% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 19.3% | ||
| Q4 24 | — | 10.3% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 15.3% |
净利率IDYAIMAX
| Q4 25 | — | 0.5% | ||
| Q3 25 | 57.4% | 19.4% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.1% |
每股收益（稀释后）IDYAIMAX
| Q4 25 | — | $0.02 | ||
| Q3 25 | $1.33 | $0.37 | ||
| Q2 25 | — | $0.20 | ||
| Q1 25 | — | $0.04 | ||
| Q4 24 | — | $0.09 | ||
| Q3 24 | $-0.60 | $0.26 | ||
| Q2 24 | $-0.68 | $0.07 | ||
| Q1 24 | $-0.53 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $786.9M | $151.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $337.9M |
| 总资产 | $1.2B | $894.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IDYAIMAX
| Q4 25 | — | $151.2M | ||
| Q3 25 | $786.9M | $143.1M | ||
| Q2 25 | — | $109.3M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | — | $100.6M | ||
| Q3 24 | $920.0M | $104.5M | ||
| Q2 24 | $701.7M | $91.6M | ||
| Q1 24 | $698.8M | $81.0M |
股东权益IDYAIMAX
| Q4 25 | — | $337.9M | ||
| Q3 25 | $1.1B | $349.5M | ||
| Q2 25 | — | $320.4M | ||
| Q1 25 | — | $299.5M | ||
| Q4 24 | — | $299.5M | ||
| Q3 24 | $1.2B | $289.4M | ||
| Q2 24 | $931.7M | $267.2M | ||
| Q1 24 | $935.3M | $258.8M |
总资产IDYAIMAX
| Q4 25 | — | $894.0M | ||
| Q3 25 | $1.2B | $889.6M | ||
| Q2 25 | — | $868.6M | ||
| Q1 25 | — | $848.3M | ||
| Q4 24 | — | $830.4M | ||
| Q3 24 | $1.2B | $847.6M | ||
| Q2 24 | $973.7M | $827.4M | ||
| Q1 24 | $961.5M | $824.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $142.2M | $29.4M |
| 自由现金流经营现金流 - 资本支出 | $142.2M | $28.0M |
| 自由现金流率自由现金流/营收 | 68.4% | 22.3% |
| 资本支出强度资本支出/营收 | 0.0% | 1.1% |
| 现金转化率经营现金流/净利润 | 1.19× | 46.11× |
| 过去12个月自由现金流最近4个季度 | $13.5M | $118.9M |
8季度趋势，按日历期对齐
经营现金流IDYAIMAX
| Q4 25 | — | $29.4M | ||
| Q3 25 | $142.2M | $67.5M | ||
| Q2 25 | — | $23.2M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | $-49.2M | $35.3M | ||
| Q2 24 | $-32.9M | $35.0M | ||
| Q1 24 | $-43.8M | $-11.0M |
自由现金流IDYAIMAX
| Q4 25 | — | $28.0M | ||
| Q3 25 | $142.2M | $64.8M | ||
| Q2 25 | — | $20.9M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | $-49.7M | $34.2M | ||
| Q2 24 | $-33.9M | $33.5M | ||
| Q1 24 | $-45.1M | $-12.1M |
自由现金流率IDYAIMAX
| Q4 25 | — | 22.3% | ||
| Q3 25 | 68.4% | 60.7% | ||
| Q2 25 | — | 22.8% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | — | 37.3% | ||
| Q2 24 | — | 37.6% | ||
| Q1 24 | — | -15.3% |
资本支出强度IDYAIMAX
| Q4 25 | — | 1.1% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 1.4% |
现金转化率IDYAIMAX
| Q4 25 | — | 46.11× | ||
| Q3 25 | 1.19× | 3.27× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | 2.16× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 9.78× | ||
| Q1 24 | — | -3.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDYA
暂无分部数据
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
